← Back to Analyst Consensus 
CPRX Hold
CATALYST PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 28, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| May 8, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| May 7, 2026 | Stephens & Co. | downgrade | Overweight → Equal-Weight | — | 54% |
| Mar 3, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Nov 7, 2025 | Citigroup | maintain | Buy → Buy | $33 | 54% |
| Mar 3, 2025 | Baird | maintain | Outperform → Outperform | $32 | 55% |
| Feb 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Feb 27, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $33 | 54% |
| Feb 4, 2025 | Baird | initiate | — → Outperform | $28 | 55% |
| Jan 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $35 | 44% |
| Jan 9, 2025 | B of A Securities | reiterate | Buy → Buy | $30 | 53% |
| Nov 18, 2024 | Stephens & Co. | initiate | — → Overweight | $35 | 54% |
| Nov 11, 2024 | Truist Securities | maintain | Buy → Buy | $36 | 54% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Aug 9, 2024 | Citigroup | maintain | Buy → Buy | $31 | 54% |
| Aug 9, 2024 | Truist Securities | maintain | Buy → Buy | $30 | 54% |
| Jun 6, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $29 | 52% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $26 | 44% |
| May 10, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Mar 27, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $29 | 52% |
| Mar 22, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $34 | 50% |
| Mar 14, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $34 | 50% |
| Mar 14, 2024 | Citigroup | initiate | — → Buy | $27 | 54% |
| Mar 7, 2024 | B of A Securities | initiate | — → Buy | $23 | 53% |
| Mar 1, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $34 | 50% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Dec 21, 2023 | Oppenheimer | initiate | — → Outperform | $30 | 52% |
| Aug 22, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $27 | 50% |
| Aug 11, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $27 | 50% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Jul 21, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Jun 21, 2023 | Truist Securities | maintain | — → Buy | $24 | 54% |
| Jun 21, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $25 | 50% |
| Jun 20, 2023 | Truist Securities | maintain | — → Buy | $24 | 54% |
| May 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Mar 20, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $24 | 44% |
| Jan 19, 2023 | Truist Securities | maintain | — → Buy | $22 | 54% |
| Dec 21, 2022 | Truist Securities | maintain | — → Buy | $18 | 54% |
| Dec 21, 2022 | HC Wainwright & Co. | maintain | — → Buy | $24 | 44% |
| Dec 20, 2022 | Piper Sandler | maintain | — → Overweight | $20 | 54% |
| Aug 24, 2022 | Roth Capital | downgrade | Buy → Neutral | $15.5 | 53% |
| Aug 11, 2022 | Truist Securities | maintain | — → Buy | $17 | 54% |
| Aug 11, 2022 | HC Wainwright & Co. | maintain | — → Buy | $18 | 44% |
| Feb 8, 2022 | HC Wainwright & Co. | maintain | — → Buy | $12 | 44% |
| Mar 18, 2021 | Roth Capital | maintain | — → Buy | $7 | 53% |
| Aug 12, 2020 | Truist Securities | maintain | — → Buy | $8 | 54% |
| May 13, 2020 | SunTrust Robinson Humphrey | maintain | — → Buy | $10 | — |
| Feb 14, 2020 | Cantor Fitzgerald | reiterate | — → Overweight | $12 | 50% |
| Dec 13, 2018 | Piper Sandler | maintain | Overweight → Overweight | $7.5 | 54% |
Price Target Trend
Apr 25, 2026 Latest: $31.67 Sep 14, 2026
EPS Estimates
0q $0.74
Lo: $0.74 Hi: $0.74
1 analysts ▲1
0y $3.17
Lo: $3.17 Hi: $3.17
1 analysts ▲1
+1y $3.18
Lo: $2.58 Hi: $3.55
3 analysts ▲1
+1q $0.82
Lo: $0.82 Hi: $0.82
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days